Studies using an antibody to ICAM-1 showed a beneficial effect in patients with IBD [62], inhibition of eosinophil recruitment to nerves may be one explanation of how this agent exerted this beneficial effect in IBD. The gene discussed is ICAM1; the disease is inflammatory bowel disease.